| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.099 | 0.002 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.008 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.093 | 0.008 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.01 |